0001096906-24-000497.txt : 20240318
0001096906-24-000497.hdr.sgml : 20240318
20240318181223
ACCESSION NUMBER: 0001096906-24-000497
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240314
FILED AS OF DATE: 20240318
DATE AS OF CHANGE: 20240318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shendelman Shoshana
CENTRAL INDEX KEY: 0001775490
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38898
FILM NUMBER: 24760434
MAIL ADDRESS:
STREET 1: C/O APPLIED THERAPEUTICS, INC.
STREET 2: 340 MADISON AVENUE, 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10173
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Applied Therapeutics, Inc.
CENTRAL INDEX KEY: 0001697532
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 545 FIFTH AVENUE, SUITE 1400
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-220-9226
MAIL ADDRESS:
STREET 1: 545 FIFTH AVENUE, SUITE 1400
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: Applied Therapeutics Inc.
DATE OF NAME CHANGE: 20170208
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-03-14
0
0001697532
Applied Therapeutics, Inc.
APLT
0001775490
Shendelman Shoshana
C/O APPLIED THERAPEUTICS, INC.
545 FIFTH AVENUE, SUITE 1400
NEW YORK
NY
10017
1
1
1
0
President and CEO
0
Common Stock
2024-03-14
4
S
0
318573.0000
5.3900
D
3817814.0000
D
Common Stock
1750000.0000
I
See footnote
Common Stock
1492094.0000
I
See footnote
Common Stock
709720.0000
I
See footnote
Common Stock
290280.0000
I
See footnote
Common Stock
88397.0000
I
See footnote
The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.37 to $5.795, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Through a grantor retained annuity trust.
Through a family trust controlled by the reporting person's spouse.
Through the reporting person's spouse.
Through a family trust controlled by the reporting person.
Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.
/s/ Shoshana Shendelman
2024-03-18